Talk / Overview

Covariate adjustment in clinical trials leads to gains in statistical power. Our simulation study quantifies the impact of covariate adjustment in different disease indications. Adopting an evidence-based approach will significantly improve the success rate of trials. New prognostic modalities such as digital pathology can further de-risk and accelerate clinical trials. Broader eligibility criteria in trials are more attractive once covariate adjustment is optimized.

Talk / Speakers

Félix Balazard

Lead data scientist, Owkin

Talk / Slides

Download the slides for this talk.Download ( PDF, 36676.83 MB)

Talk / Highlights

AI for Evidence-Based Covariate Adjustment in Clinical Trials

With Félix BalazardPublished April 27, 2022

AMLD / Global partners